Tiny stem cell companies close in on major heart disease goals Ruby Khatun Khatun20 Dec 2017 9:30 AM ISTNEW YORK: The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes has given way to a long list of...
Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
Novartis generics arm says may sell or end some products Ruby Khatun Khatun18 Dec 2017 9:30 AM ISTZURICH: Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on...
Torrent completes acquisition of branded business of Unichem Labs Ruby Khatun Khatun16 Dec 2017 3:58 PM ISTNew Delhi: Torrent Pharmaceuticals said it has completed the Rs 3,600 crore acquisition of Unichem's branded business for India and Nepal.The...
Cadila gets USFDA nod for generic drug to treat Parkinson Ruby Khatun Khatun15 Dec 2017 4:08 PM ISTNew Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
Natco Pharma raises Rs 915 crore via QIP Ruby Khatun Khatun15 Dec 2017 10:36 AM ISTNew Delhi: Natco Pharma has raised Rs 915 crore through issue of securities to qualified institutional investors (QIP), according to a regulatory...
Lupin gets USFDA nod for generic contraceptive tablets Ruby Khatun Khatun15 Dec 2017 10:30 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
USFDA accepts application for Indivior's new schizophrenia drug Ruby Khatun Khatun15 Dec 2017 9:45 AM ISTU.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
Novartis CAR-T therapy leads to durable response in lymphoma study Ruby Khatun Khatun11 Dec 2017 10:45 AM ISTPatients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy...
Roche drug cocktail doubles chance of holding lung cancer at bay Ruby Khatun Khatun9 Dec 2017 9:45 AM ISTZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
Shared latest data on dengue vaccine with authorities: Sanofi India Ruby Khatun Khatun6 Dec 2017 4:58 PM ISTNew Delhi: Awaiting approval for its dengue vaccine in India, French drug major Sanofi said it has shared data with authorities here about the risk of...
